Patent ID: 7005119

Claim:
A method of radio imaging cardiovascular tissue of a subject comprising administering intravenously to a subject an effective amount of pharmaceutical composition comprising: (i) an imaging agent including a substantially pure stereoisomer of a radionuclide labeled β-methyl fatty acid analog having a formula, R 1 (CH 2 ) n C(R 3 )HCH 2 COOR 2 in which R 1 is selected from the group consisting of hydrogen, fluorine, an aryl group, a substituted aryl group and an iodothiophene group; R 2 is selected from the group consisting of a hydrogen, a primary amine, a secondary amine, a tertiary amine, an allyl group, a substituted alkyl group, an aryl group, and a substituted aryl group; R 3 is selected from the group consisting of a hydrogen, a methyl, a hydroxyl, a keto ester, a methoxy, a halide, and an amine and n is greater than or equal to 12; and (ii) a chelating structure.